Qiagen NV (QGEN)
42.81
+0.48
(+1.13%)
USD |
NYSE |
May 01, 16:00
42.81
0.00 (0.00%)
After-Hours: 20:00
Qiagen 1 Year Total Returns (Daily): -5.25% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 30, 2024 | -5.25% |
| April 29, 2024 | -5.32% |
| April 26, 2024 | -5.33% |
| April 25, 2024 | -7.07% |
| April 24, 2024 | -8.94% |
| April 23, 2024 | -7.23% |
| April 22, 2024 | -8.72% |
| April 19, 2024 | -12.12% |
| April 18, 2024 | -13.95% |
| April 17, 2024 | -15.21% |
| April 16, 2024 | -15.60% |
| April 15, 2024 | -14.85% |
| April 12, 2024 | -13.16% |
| April 11, 2024 | -11.06% |
| April 10, 2024 | -10.14% |
| April 09, 2024 | -8.86% |
| April 08, 2024 | -9.88% |
| April 05, 2024 | -10.36% |
| April 04, 2024 | -9.50% |
| April 03, 2024 | -8.05% |
| April 02, 2024 | -8.24% |
| April 01, 2024 | -7.63% |
| March 28, 2024 | -6.15% |
| March 27, 2024 | -7.98% |
| March 26, 2024 | -7.61% |
| Date | Value |
|---|---|
| March 25, 2024 | -7.35% |
| March 22, 2024 | -4.69% |
| March 21, 2024 | -6.02% |
| March 20, 2024 | -4.27% |
| March 19, 2024 | -4.72% |
| March 18, 2024 | -4.44% |
| March 15, 2024 | -4.36% |
| March 14, 2024 | -5.15% |
| March 13, 2024 | -4.73% |
| March 12, 2024 | -2.97% |
| March 11, 2024 | -2.15% |
| March 08, 2024 | -3.49% |
| March 07, 2024 | -3.34% |
| March 06, 2024 | -5.25% |
| March 05, 2024 | -5.28% |
| March 04, 2024 | -5.28% |
| March 01, 2024 | -4.20% |
| February 29, 2024 | -7.02% |
| February 28, 2024 | -6.12% |
| February 27, 2024 | -6.23% |
| February 26, 2024 | -4.93% |
| February 23, 2024 | -5.64% |
| February 22, 2024 | -6.46% |
| February 21, 2024 | -9.37% |
| February 20, 2024 | -10.57% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-28.74%
Minimum
Oct 08 2019
112.8%
Maximum
Oct 08 2020
4.72%
Average
-1.34%
Median
1 Year Total Returns (Daily) Benchmarks
| MoonLake Immunotherapeutics | 92.16% |
| LENZ Therapeutics Inc | -- |
| Thermo Fisher Scientific Inc | 2.77% |
| uniQure NV | -77.31% |
| ProQR Therapeutics NV | -11.01% |